retatrutide weight loss clinical trial Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In retatrutide clinical trial south africa

Donate blood, platelets or plasma in March and receive a free A1C test plus an Amazon gift card.ENCINITAS, CA The American Red Cross asked for the public's help this week to replenish its blood supply after winter storms impacted donations and led to a severe shortage."Some parts of the nation are still clearing snow, but the threat of severe spring weather is already growing," a statement from the organization said

To substantiate and enhance these initial findings, there is a pressing need for more comprehensive prospective investigations conducted on a larger scale

The patient was then admitted to the hospital on the internal medicine service for further testing

When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to get FDA approval since 2014 and immediately became the go-to weight-loss treatment

The average patient who is closely following all of the related recommendations of the medical weight loss program can expect to lose an average of 5 pounds per month

Eli Lillys share price more than doubled in the same period